Overview
Nucala is approved by the U.S. Food and Drug Administration (FDA) as an add-on maintenance treatment for adults with chronic obstructive pulmonary disease (COPD) who have an eosinophilic phenotype (a type of…

Overview
Dupixent is approved by the U.S. Food and Drug Administration (FDA) as an add-on maintenance treatment for adults with chronic obstructive pulmonary disease (COPD) who have an eosinophilic phenotype (high levels…

Overview
Yupelri is approved by the U.S. Food and Drug Administration (FDA) for the maintenance treatment of chronic obstructive pulmonary disease (COPD). It is prescribed to help manage symptoms of COPD on a daily basis…

Overview
Ohtuvayre is approved by the U.S. Food and Drug Administration (FDA) for the maintenance treatment of chronic obstructive pulmonary disease (COPD) in adults. It is prescribed to help manage symptoms and improve…

Overview
Trelegy is a prescription drug approved by the U.S. Food and Drug Administration (FDA) for daily maintenance treatment of chronic obstructive pulmonary disease (COPD). Trelegy helps prevent bronchospasms…

Overview
Breztri is a prescription drug approved by the U.S. Food and Drug Administration (FDA) as long-term, daily maintenance treatment for airflow obstruction in people with chronic obstructive pulmonary disease…

Overview
Duaklir Pressair is a prescription drug approved by the Food and Drug Administration (FDA) as long-term maintenance treatment for airflow obstruction in people with chronic obstructive pulmonary disease (COPD).…

Overview
Aralast NP is a prescription drug approved by the Food and Drug Administration (FDA) as maintenance therapy in adults who have clinically evident emphysema due to Alpha-1 antitrypsin (AAT) deficiency, a rare…

Overview
Glassia is a prescription drug approved by the Food and Drug Administration (FDA) as maintenance therapy in adults who have clinically evident emphysema due to Alpha-1 antitrypsin deficiency, a rare genetic…

Overview
Anoro Ellipta is a prescription drug approved by the Food and Drug Administration (FDA) as long-term, once-daily maintenance treatment for airflow obstruction in people with chronic obstructive pulmonary disease…

Overview
Zemaira is a prescription drug approved by the Food and Drug Administration (FDA) as maintenance therapy in adults who have clinically evident emphysema due to Alpha-1 antitrypsin (AAT) deficiency, a rare…

Overview
Incruse Ellipta is a prescription drug approved by the Food and Drug Administration (FDA) for long-term, once-daily maintenance treatment of airflow obstruction in people with chronic obstructive pulmonary…

Overview
Stiolto Respimat is a prescription drug approved by the Food and Drug Administration (FDA) as long-term, once-daily maintenance treatment for airflow obstruction in people with chronic obstructive pulmonary…

Overview
Bevespi Aerosphere is a prescription drug approved by the Food and Drug Administration (FDA) as long-term maintenance treatment for airflow obstruction in people with chronic obstructive pulmonary disease…

Overview
Daliresp is a prescription drug approved by the Food and Drug Administration (FDA) to reduce the risk of exacerbations in people with chronic obstructive pulmonary disease (COPD), chronic bronchitis, and a…

Overview
Striverdi Respimat is a prescription drug approved by the Food and Drug Administration (FDA) in 2014 for daily maintenance of bronchospasms in chronic obstructive pulmonary disease (COPD). Striverdi Respimat is…

Overview
Breo Ellipta is a prescription drug approved by the Food and Drug Administration (FDA) in 2013 for daily maintenance treatment in cases of chronic obstructive pulmonary disease (COPD). Breo Ellipta helps…

Overview
Combivent Respimat is a prescription drug approved by the Food and Drug Administration (FDA) in 2011 to prevent bronchospasm in people with chronic obstructive pulmonary disease (COPD). Combivent Respimat is…

Overview
Tudorza is a prescription drug approved by the Food and Drug Administration (FDA) for maintenance treatment of bronchospasm in chronic obstructive pulmonary disease (COPD). Tudorza is not indicated for rescue…

Overview
Atrovent is a prescription drug approved by the Food and Drug Administration (FDA) for the maintenance treatment of bronchospasms caused by asthma, allergies, chronic obstructive pulmonary disease (COPD), and…

Overview
Perforomist is a prescription drug first approved by the Food and Drug Administration (FDA) in 2001 for maintenance of asthma and prevention of bronchospasms in chronic obstructive pulmonary disease (COPD)…

Overview
Serevent is a prescription drug approved by the Food and Drug Administration (FDA) to treat asthma and prevent bronchospasms in people age 4 and older with reversible obstructive airway problems such as chronic…

Overview
Spiriva is a prescription drug approved by the Food and Drug Administration (FDA) for long-term, once-daily maintenance treatment of bronchospasms in people with chronic obstructive pulmonary disease (COPD), and…

Overview
Symbicort is a prescription drug approved by the Food and Drug Administration (FDA) in 2006 for the treatment of asthma and 2009 for chronic obstructive pulmonary disease (COPD). Symbicort helps prevent…

Overview
Theo-24 is a prescription drug approved by the Food and Drug Administration (FDA) in 1983 to treat the symptoms of reversible airflow diseases such as asthma and chronic bronchitis. In severe cases of chronic…